Peter Kellogg

Peter N.
Kellogg is currently an Independent Director at Alnylam Pharmaceuticals, Inc. since 2023.
Mr. Kellogg is also a Director at Idorsia Pharmaceuticals Ltd. and serves as Chief Financial Officer & Executive Vice President at Receptos LLC.
Formerly, Mr. Kellogg was an Independent Director at Yield10 Bioscience, Inc. from 2011 to 2020.
Mr. Kellogg was a Non-Executive Director at Idorsia Ltd. from 2021 to 2024.
Mr. Kellogg was a Director at Juno Therapeutics, Inc. Mr. Kellogg was Chief Financial Officer & Executive Vice President at Biogen MA, Inc. in 2003.
Mr. Kellogg was Chief Financial Officer & Executive Vice President at Merck & Co., Inc. from 2007 to 2014.
Mr. Kellogg was Senior Vice President-eCommerce at PepsiCo, Inc. in 2000.
Mr. Kellogg was Chief Financial Officer & Executive Vice President at Schering-Plough Corp.
in 2009.
Mr. Kellogg was Chief Financial Officer & Executive Vice President at Biogen, Inc. from 2003 to 2007.
Mr. Kellogg was Principal at Pepsi-Cola International Ltd. (New York).
Mr. Kellogg was Principal at Pepsi-Cola North America.
Mr. Kellogg was Senior Vice President at PepsiCo Food International.
Mr. Kellogg was Executive Vice President at Biogen Idec New Ventures, Inc. from 2000 to 2007.
Mr. Kellogg was Chief Financial Officer & Executive VP-Finance at Biogen Idec, Inc. (North Carolina) from 2003 to 2007.
Mr. Kellogg was Chief Financial Officer & Senior Vice President at Frito-Lay International from 1998 to 2000.
Mr. Kellogg was Chief Financial Officer & Executive Vice President at Merck Sharp & Dohme Corp.
from 2007 to 2009.
Mr. Kellogg was Chief Corporate Strategy Officer & Executive VP at Celgene Corp.
from 2018 to 2019.
Education includes an undergraduate degree from Princeton University in 1978 and an MBA from The Wharton School of the University of Pennsylvania in 1982.